Newer clot-buster may offer a safe, effective way to treat ischemic stroke in mobile stroke units

Compared with the standard clot-busting medication alteplase, the newer clot-buster tenecteplase may offer a safe, effective and simpler way to treat ischemic (clot-caused) stroke in mobile stroke units, according to real-world experiences detailed in a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2024.

MHRA puts technology in the spotlight in 2024/25 business plan – Pharmaceutical Technology

Credit: Ralf Liebhold / Shutterstock. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has unveiled a new business plan to build on the launch

October 8, 2024

Novo Nordisk restarts advertising for obesity drug Wegovy with new campaign

Novo Nordisk is restarting its Wegovy advertising with a new introspective campaign encouraging people to “Believe On” after an eight-month pause on its campaign related

January 17, 2024

Molecular Devices opens custom-built site in Cardiff for manufacturing of patient-derived organoids

Today, Molecular Devices, LLC., a leading high-performance life science solutions provider, officially opened its custom-built site in Cardiff, UK.

June 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.